Most skincare addresses what happens after your skin ages: the appearance of wrinkles, loss of visible firmness, and dullness. But four PhD longevity scientists asked a different question: what if you could target the cellular process that causes visible aging in the first place?

Their answer is OS-01, the first peptide scientifically proven to address senescent cells — the damaged "zombie cells" that accumulate with age and accelerate visible skin decline. The result: the first topical clinically validated to address visible skin aging at the source. In a double-blind 12-week clinical study of OS-01 FACE:

This isn't skincare with better marketing. It's skincare with better science. And real results.

Get 15% off + free gifts

^{*Explore the claims at oneskin.co}